Literature DB >> 7076276

Comparison of the receptors for IgE of various rat basophilic leukaemia cell lines. II. Studies with different anti-receptor antisera.

A Froese, R M Helm, D H Conrad, C Isersky, T Ishizaka.   

Abstract

Receptors for IgE of rat basophilic leukaemia (RBL) cells, maintained in different laboratories were isolated by means of various anti-receptor antisera, and characterized by sodium dodecyl sulphate (SDS)-polyacrylamide gel electrophoresis. Most antisera were shown to react with a receptor designated H and which, as shown previously, could be isolated by IgE-Sepharose but not by a combination of IgE and anti-IgE. Only two highly purified anti-receptor antibody preparations, which had been purified by adsorption to and elution from rat basophilic leukaemia cells, reacted primarily with a second kind of receptor molecule which had previously been designated R. Some indirect evidence was obtained which suggests that H is a highly immunogenic molecule. It was confirmed that the apparent molecular weight of H-like molecules varied on different RBL cell lines.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076276      PMCID: PMC1555351     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  11 in total

1.  Evidence that the "mouse mastocytoma" cell line (MCT-1) is of rat origin.

Authors:  R P Siraganian; H Metzger
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

2.  Triggering of cultured neoplastic mast cells by antibodies to the receptor for IgE.

Authors:  C Isersky; J D Taurog; G Poy; H Metzger
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

3.  Characterization of the target cell receptor for IgE. V. Studies with an antiserum specific for the receptor.

Authors:  D H Conrad; R M Helm; S H Yiu; A Froese; T Ishizaka; K Ishizaka
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

4.  The binding of antibodies to the solubilized and membrane-integrated mouse and rat receptor for IgE.

Authors:  C Isersky; G R Mendoza; H Metzger
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

5.  Characterization of the target cell receptor for IgE. III. properties of the receptor isolated from rat basophilic leukemia cells by affinity chromatography.

Authors:  D H Conrad; A Froese
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

6.  Evidence for antibody activity against the receptor for IgE in a rabbit antiserum prepared against IgE-receptor complexes.

Authors:  D H Conrad; A Froese; T Ishizaka; K Ishizaka
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

7.  Histamine release from rat mast cells by antibodies against rat basophilic leukemia cell membrane.

Authors:  T Ishizaka; T H Chang; M Taggart; K Ishizaka
Journal:  J Immunol       Date:  1977-11       Impact factor: 5.422

8.  Stimulation of phospholipid methylation, Ca2+ influx, and histamine release by bridging of IgE receptors on rat mast cells.

Authors:  T Ishizaka; F Hirata; K Ishizaka; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

9.  Triggering of histamine release from rat mast cells by divalent antibodies against IgE-receptors.

Authors:  T Ishizaka; K Ishizaka
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

10.  The presence of two kinds of receptors for IgE on rat mast cells.

Authors:  A Froese
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

View more
  2 in total

Review 1.  The RBL-2H3 cell line: its provenance and suitability as a model for the mast cell.

Authors:  Egle Passante; Neil Frankish
Journal:  Inflamm Res       Date:  2009-08-09       Impact factor: 4.575

2.  Comparison of the receptors for IgE of various rat basophilic leukaemia cell lines. I. Receptors isolated by IgE-sepharose and IgE and anti-IgE.

Authors:  A Froese; R M Helm; D H Conrad; C Isersky; T Ishizaka; A Kulczycki
Journal:  Immunology       Date:  1982-05       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.